RECQL4 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to RECQL4 Antibody

RECQL4 antibody (B-3) is a mouse monoclonal IgM kappa antibody developed for detecting the RECQL4 protein across species, including humans, mice, and rats. It is widely used in techniques such as:

  • Western blotting (WB)

  • Immunoprecipitation (IP)

  • Immunofluorescence (IF)

  • Enzyme-linked immunosorbent assay (ELISA)

This antibody targets RECQL4, a member of the RecQ helicase family critical for DNA replication and repair .

Key Discoveries:

  • DNA Repair Mechanisms: RECQL4 interacts with PARP1 to facilitate DNA double-strand break (DSB) repair via alternative non-homologous end joining (alt-NHEJ). PARP1 recruits RECQL4 to damage sites and enhances its DNA strand annealing activity .

  • Cancer Relevance:

    • Overexpression of RECQL4 correlates with increased tumor mutation burden in breast and prostate cancers .

    • In triple-negative breast cancer (TNBC), RECQL4 protein levels predict cisplatin chemotherapy response .

  • Disease Link: Mutations in RECQL4 cause Rothmund-Thomson syndrome, characterized by skeletal defects and cancer predisposition .

Table 2: PARP1-RECQL4 Functional Interactions

Interaction AspectExperimental Finding
PARylation DependencyRECQL4 recruitment to DSBs requires PARP1-mediated PARylation .
Activity ModulationPARylation reduces RECQL4 helicase activity; PARG reverses this effect .
Binding DomainsPARP1 binds RECQL4 via its N-terminal (aa 1–461) and C-terminal (aa 662–1,014) regions .

Mechanistic Insights:

  • RECQL4 displaces replication protein A (RPA) from single-stranded DNA (ssDNA) to promote microhomology annealing during alt-NHEJ .

  • Helicase-inactive RECQL4 mutants retain annealing capabilities, indicating separable functional domains .

Implications for Cancer Research and Therapeutics

  • Biomarker Potential: Elevated RECQL4 levels in TNBC may serve as a predictive marker for cisplatin resistance .

  • Therapeutic Targeting: Inhibiting RECQL4-PARP1 interactions could sensitize cancer cells to DNA-damaging agents .

"RECQL4’s annealing activity, distinct from its helicase function, provides a novel target for disrupting error-prone DNA repair pathways in cancer."

Product Specs

Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Stored at -20°C. Avoid freeze/thaw cycles.
Lead Time
Typically, we can ship products within 1-3 business days of receiving your order. Delivery time may vary depending on the purchase method or location. Please contact your local distributor for specific delivery details.
Synonyms
ATP dependent DNA helicase Q4 antibody; ATP-dependent DNA helicase Q4 antibody; DNA helicase antibody; DNA helicase, RecQ like type 4 antibody; RECQ 4 antibody; RECQ L4 antibody; RecQ protein 4 antibody; RecQ protein like 4 antibody; RecQ protein-like 4 antibody; RecQ-like type 4 antibody; RecQ4 antibody; RECQ4_HUMAN antibody; RECQL 4 antibody; RECQL4 antibody; RTS antibody
Target Names
RECQL4
Uniprot No.

Target Background

Function
RECQL4 is a DNA-dependent ATPase that may play a role in regulating chromosome segregation.
Gene References Into Functions
  1. Research indicates that RECQL4 DNA helicase (RECQL4) influences the selection of DNA end-joining repair and homologous recombination DNA repair pathways in a cell cycle-dependent manner. PMID: 29229926
  2. An analysis of RECQL4 variants in Chinese patients with Rothmund-Thomson syndrome was conducted. PMID: 29462647
  3. RECQL4 is an important participant in homologous recombination (HR)-dependent DNA double-strand break repair. PMID: 27320928
  4. These findings solidify Hrq1 as a true RecQ4 homolog and establish it as a leading model for understanding how RecQ4 mutations lead to genomic instability and disease. PMID: 28334827
  5. High RECQL4 expression is associated with Cisplatin Resistance in Gastric Cancer. PMID: 27013200
  6. Mutations in RECQL4 are responsible for the majority of cases of Rothmund-Thomson syndrome. RECQL4 plays a significant role not only in cancer development but also in the aging process. PMID: 27287744
  7. High RecQL4 expression is associated with osteosarcoma. PMID: 27813658
  8. This study demonstrates, for the first time, that due to its mitochondrial functions, the accessory mitochondrial replication helicase RECQL4 prevents the invasive step in the neoplastic transformation process. PMID: 26906415
  9. These results reveal novel potential roles of RecQ4 in DNA replication and genome stability. PMID: 26888063
  10. RECQL4 is a tumor promoter in established breast cancers. PMID: 26690729
  11. RecQL4-dependent association of Mcm10 and Ctf4 with replication origins appears to be the initial crucial step controlled by S phase promoting kinases and checkpoint pathways for the initiation of DNA replication in human cells. PMID: 25602958
  12. No RECQL4 mutations were found in the BGS group without poikiloderma, confirming that RECQL4 sequencing was not indicated for this phenotype. PMID: 24635570
  13. This finding provided the key to unravel the correlation between the RECQL4 genotype and the mild phenotype of the two siblings of Rothmund-Thomson Syndrome. PMID: 24518840
  14. The N-terminus of human RecQL4 serves as a complex moderator of DNA transactions mediated by multiple DNA-binding sites. PMID: 25336622
  15. The highly cancer-prone RECQ4 ID mutant failed to interact with p32, leading to increases in mtDNA copy number and mitochondrial dysfunction. PMID: 24746816
  16. Dysfunction of RECQL4 increases DNA damage and triggers premature senescence in both human and mouse cells, which may contribute to symptoms in Rothmund-Thompson syndrome patients. PMID: 24832598
  17. Elevated expression of RECQL4 accompanies progression of the Rothmund-Thomson Syndrome into osteosarcoma in humans and mice. PMID: 24924172
  18. Molecular analyses reveal the presence of a novel truncating mutation and a known missense mutation, p.R1021W, located outside of the helicase domain. This mutation has been found in several patients either in a compound heterozygous state or alone. PMID: 23899764
  19. In vitro studies demonstrated that defects in RECQL4 impair homologous recombination, making BC cells more sensitive to DNA-damaging agents. PMID: 24072219
  20. RECQL4 and p53 enhance the activity of polymerase gamma and maintain the integrity of the human mitochondrial genome. PMID: 24067899
  21. Overexpression of RecQL4 due to gene amplification plays a crucial role in human breast tumor progression. PMID: 23894508
  22. RECQL4 may hold a unique position as a bridge between cancer and aging, functioning as a guardian not only of the nuclear genome but also of the mitochondrial genome. PMID: 22940096
  23. RECQL4 exhibits a preferential activity in vitro on telomeric substrates containing thymine glycol. PMID: 23683351
  24. Our findings provide further support for a helicase-dependent cellular function of RECQL4. PMID: 23238538
  25. Nuclear exporting signals-mediated RecQL4 export to the cytoplasm is essential for the maintenance of mitochondrial genome stability. PMID: 22824301
  26. Despite low-sequence homology, the N-terminus of the human RecQL4 helicase was determined to be a well-defined structure that carries an overall helical fold similar to homeodomain DNA-binding proteins but lacks their archetypical, minor groove-binding N-terminal extension. PMID: 22730300
  27. Measurements of mitochondrial bioenergetics showed a reduction in the mitochondrial reserve capacity after lentiviral knockdown of RECQL4 in two different primary cell lines. PMID: 22296597
  28. RECQL4 is essential for the transport of p53 to mitochondria. PMID: 22357944
  29. BLM and RECQL4 interact physically and functionally in vivo and in vitro. PMID: 22544709
  30. These observations help explain the underlying molecular etiology of the disease, and our findings provide insight into the genotype and phenotype association among RECQL4 syndromes. PMID: 22885111
  31. The study concludes that the function of the RecQ helicases has diverged during evolution, with RecQL4 acquiring a function that allows cells to negotiate DNA replication templates that have been damaged by ionizing radiation. PMID: 22508716
  32. Single Nucleotide Polymorphisms in the RECQL4 gene are associated with glioblastoma. PMID: 22017238
  33. The role of RECQL4 in telomere maintenance is being investigated. PMID: 22039056
  34. RecQL4, the N-terminal portion of which shares similarity with Sld2 known to be required for assembly of a replication complex in yeasts, is unique in that it has been shown to be essential for the initiation phase of normal DNA replication. PMID: 21436139
  35. The N-terminal domain of RECQL4 is sufficient for cell viability. The C-terminal region, including the helicase domain of RECQL4, is implicated in DNA repair. PMID: 21256165
  36. The study shows that RecQL4 is an essential factor for prostate carcinogenesis. PMID: 21045146
  37. The study shows that RECQL4 is recruited early to laser-induced double-strand breaks and remains for a shorter duration than WRN and BLM. PMID: 20222902
  38. Collectively, these data indicate that specific biochemical activities and protein partners of RecQ4 are conserved with those of the other RecQ helicases. PMID: 20451470
  39. These results indicate that RECQ1 and RECQL4 are integral components of the human replication complex and play distinct roles in DNA replication initiation and replication fork progression in vivo. PMID: 20065033
  40. The RECQL4 gene structure is unusual because it contains many small introns <100 bp. A proband with Rothmund-Thomson syndrome was identified who has a novel 11-bp intronic deletion; this mutation results in a 66-bp intron too small for proper splicing. PMID: 12016592
  41. Two novel exonic single nucleotide polymorphisms and a minisatellite repeat are characterized. PMID: 12601557
  42. RECQL4 mutations were not found in poikiloderma with neutropenia in Navajo and non-Navajo patients. PMID: 12673665
  43. The RECQL4 gene is not a frequent target for somatic mutations in sporadic osteosarcoma. PMID: 15221963
  44. RECQL4 from HeLa cells interacts with ubiquitin ligases UBR1 and UBR2. PMID: 15317757
  45. The human diseases connected with RECQL4 mutations appear distinct in their clinical phenotypes from Bloom or Werner's syndrome. PMID: 15960976
  46. Baller-Gerold syndrome (BGS) in a subgroup of patients is due to RECQL4 mutations and could be integrated into a clinical spectrum that encompasses Rothmund-Thomson syndrome (RTS) and RAPADILINO syndrome. PMID: 15964893
  47. Findings suggest a role for RECQL4 in the repair of DNA double-strand breaks by homologous recombination and shed new light onto RECQL4's function in human cells. PMID: 16141230
  48. RECQ4 lacks a detectable DNA helicase activity and is mutated in Rothmund-Thomson syndrome. PMID: 16214424
  49. It is particularly challenging to establish precise genotype-phenotype correlations in RECQL4-related syndromes. This is likely due to the complex and multiple cellular networks that RECQL4 is associated with. PMID: 16617241
  50. These results suggest that enhanced oxidant sensitivity in RECQL4-deficient fibroblasts derived from RTS patients could be attributed to abnormal DNA metabolism and proliferation failure. PMID: 16678792

Show More

Hide All

Database Links

HGNC: 9949

OMIM: 218600

KEGG: hsa:9401

UniGene: Hs.31442

Involvement In Disease
Rothmund-Thomson syndrome (RTS); RAPADILINO syndrome (RAPADILINOS); Baller-Gerold syndrome (BGS)
Protein Families
Helicase family, RecQ subfamily
Subcellular Location
Cytoplasm. Nucleus.
Tissue Specificity
Ubiquitously expressed, with highest levels in thymus and testis.

Q&A

What applications are RECQL4 antibodies most commonly used for in research?

RECQL4 antibodies are widely employed across several experimental applications with varying recommended dilutions:

ApplicationRecommended DilutionNotes
Western Blot (WB)1:1000-1:5000Detects 145-150 kDa band in human samples
Immunoprecipitation (IP)0.5-4.0 μg per 1-3 mg lysateEffective in HeLa cell lysates
Immunohistochemistry (IHC)1:50-1:500May require antigen retrieval with TE buffer pH 9.0
Immunofluorescence (IF/ICC)1:200-1:800Successful in detecting nuclear and mitochondrial localization
Immunofluorescence (IF-P)1:50-1:500For paraffin-embedded sections

When selecting an application, consider that RECQL4 shows both nuclear and mitochondrial localization. Multiple studies have confirmed RECQL4's presence in mitochondria using various antibodies from different vendors, with coefficients of co-localization with MitoTracker Red ranging from 0.128 to higher values in perinuclear regions .

How do I choose the right RECQL4 antibody for my research?

Selection should be based on:

  • Target region specificity: Different antibodies target distinct domains of RECQL4:

    • N-terminal antibodies (AA 1-652): Detect the Sld2-like domain critical for DNA replication

    • C-terminal antibodies (AA 1134-1162): Recognize the region containing the helicase motifs

    • Internal region antibodies (AA 200-337): Target conserved regions

  • Experimental validation: Choose antibodies with published validation in your application of interest. For example, antibodies verified in RECQL4 knockdown/knockout models provide greater confidence in specificity .

  • Host species compatibility: Consider the host species (rabbit, mouse) when designing multiplex staining experiments to avoid cross-reactivity.

  • Reactivity with target species: Verify that the antibody has been validated in your species of interest (human, mouse) .

How can I validate the specificity of my RECQL4 antibody?

Proper validation is essential to ensure experimental rigor:

  • Positive controls: Use cell lines known to express RECQL4 (HeLa, HepG2) .

  • Knockdown/knockout validation:

    • Use siRNA-mediated knockdown (targeting sequence: CAAUACAGCUUACCGUACA) to reduce RECQL4 expression by ~90% .

    • Alternatively, employ lentiviral shRNA constructs for stable knockdown .

    • Verify knockdown efficiency by western blotting and Q-PCR before using for antibody validation.

  • Molecular weight confirmation: Verify that detected bands match the expected molecular weight of RECQL4 (calculated: 133 kDa; observed: 145-150 kDa) .

  • Multiple antibody confirmation: Use antibodies targeting different epitopes to confirm specificity. Studies have employed antibodies from Sigma, Santa Cruz, and custom sources with consistent results .

How can I detect RECQL4 recruitment to DNA damage sites?

RECQL4 is rapidly recruited to DNA double-strand breaks (DSBs). To study this phenomenon:

  • Laser microirradiation approach:

    • Use confocal laser scanning microscopy with calibrated laser settings

    • At >10% laser intensity, both single-strand breaks (SSBs) and DSBs are produced

    • RECQL4 recruitment can be observed within 5 seconds after microirradiation

    • Co-stain with γ-H2AX to confirm DSB induction and 53BP1 as a DSB repair factor

  • Live-cell imaging with GFP-RECQL4:

    • Transiently transfect cells with GFP-RECQL4 expression constructs

    • Monitor real-time recruitment to laser-induced damage

    • Compare dynamics with other RecQ helicases (GFP-WRN or GFP-BLM) as controls

  • Key controls:

    • Use 8% laser intensity (generates only SSBs) versus 18% intensity (generates DSBs)

    • Verify DSB induction by immunostaining for γ-H2AX

    • Include XRCC1 (SSB repair marker) and 53BP1 (DSB repair marker) as controls

How do I detect RECQL4 interactions with other DNA repair proteins?

RECQL4 interacts with several key DNA repair proteins. To study these interactions:

  • Co-immunoprecipitation protocol:

    • Prepare cell extracts with RIPA buffer containing protease inhibitors

    • Add benzonase (0.1 U/μl) with 1 μM Mg²⁺ to eliminate DNA-mediated interactions

    • Use 100-200 μg of clarified lysate with anti-RECQL4 antibody or anti-tag antibody

    • Include IgG control to assess non-specific binding

    • Wash beads with high salt (500 mM NaCl) followed by IP buffer washes

    • For PARP1 interaction studies, also perform reciprocal IPs with anti-PAR antibody

  • In vitro protein interaction assays:

    • Mix purified RECQL4 (10 pmol) with purified partner protein (e.g., BLM, 20 pmol)

    • Incubate in helicase buffer for 90 min at 4°C

    • Use antibody-coated protein G agarose beads for pull-down

    • Analyze interactions by western blotting

  • Enhanced detection in specific cell cycle phases:

    • The interaction between RECQL4 and BLM is enhanced during S-phase and after ionizing radiation

    • Consider synchronizing cells or treating with DNA damaging agents to enhance detection of certain interactions

What methods can detect post-translational modifications of RECQL4?

RECQL4 undergoes several post-translational modifications, particularly PARylation by PARP1:

  • Detection of PARylated RECQL4:

    • Immunoprecipitate RECQL4 using specific antibodies

    • Probe with anti-PAR antibodies (e.g., Trevigen 4336-BPC-100)

    • Alternatively, pull down with anti-PAR antibodies and probe for RECQL4

    • Include PARP inhibitor treated controls to confirm specificity

  • Mapping modification sites:

    • Generate truncation mutants of RECQL4 (N-terminal and C-terminal regions)

    • Express as tagged constructs in cells

    • Perform immunoprecipitation followed by western blotting with anti-PAR antibodies

    • RECQL4 is PARylated at both N- and C-terminal regions

  • Functional impact assessment:

    • Use PARP inhibitors to prevent PARylation

    • Compare recruitment of RECQL4 to DNA damage sites with and without PARP inhibition

    • Assess strand annealing activity of purified RECQL4 with and without PARylation in vitro

How should I optimize Western blotting for RECQL4 detection?

RECQL4 can be challenging to detect due to its size (145-150 kDa) and variable expression levels:

  • Sample preparation optimizations:

    • For nuclear RECQL4: Use nuclear extraction protocols with high salt (500 mM NaCl)

    • For mitochondrial RECQL4: Isolate mitoplasts using digitonin treatment

    • Include protease inhibitors in all buffers to prevent degradation

  • Gel and transfer considerations:

    • Use 4-15% gradient SDS-PAGE gels for optimal separation

    • Consider longer transfer times (overnight at lower voltage) for high molecular weight proteins

    • Validate transfer efficiency with Ponceau staining

  • Antibody dilution and incubation:

    • Start with 1:1000 dilution for most antibodies

    • Incubate primary antibody overnight at 4°C

    • Use 5% non-fat milk in TBST for blocking (45 minutes at room temperature)

  • Detection systems:

    • Enhanced chemiluminescence (ECL) substrates work well for RECQL4 detection

    • Image acquisition using digital systems (e.g., Bio-Rad ChemiDoc)

What controls should I include when studying RECQL4 knockdown effects?

When studying the effects of RECQL4 depletion:

  • Knockdown approaches and validation:

    • siRNA transfection: Use 100 pmol of RECQL4-targeted siRNA (sequence: CAAUACAGCUUACCGUACA) with Lipofectamine 2000

    • For more efficient knockdown, perform sequential transfections 24 hours apart

    • Always include non-targeting siRNA controls (e.g., ON-TARGET plus non-targeting siRNA #1, Dharmacon)

    • Verify knockdown by both western blotting and qPCR (expect ~90% reduction)

  • Experimental controls for functional studies:

    • Include both wild-type cells and cells with other RecQ helicase knockdowns (BLM, WRN) for comparison

    • For rescue experiments, use RECQL4 constructs resistant to siRNA targeting

    • Include helicase-dead mutants (K508A) to distinguish helicase-dependent functions

    • When investigating RECQL4-BLM cooperation, examine both single and double knockdowns

  • Phenotypic assays to verify knockdown effects:

    • Proliferation assays (show reduced growth in RECQL4-deficient cells)

    • Sister chromatid exchange frequency (increased in RECQL4-deficient cells)

    • γ-H2AX and 53BP1 foci persistence after DNA damage (prolonged in RECQL4-deficient cells)

How can I monitor RECQL4 biochemical activities in vitro?

RECQL4 possesses several biochemical activities that can be measured:

  • Helicase activity assay:

    • Use radiolabeled fork duplex substrates (0.5 nM concentration)

    • Reaction buffer: 30 mM Tris-HCl pH 7.4, 50 mM KCl, 5 mM MgCl₂, 1 mM DTT, 100 μg/ml BSA, 10% glycerol, 5 mM ATP

    • Incubate for 30 minutes at 37°C

    • Analyze by 10% native PAGE electrophoresis

    • Note: RECQL4 has weak helicase activity often masked by its strand annealing activity

    • Use short fork duplex DNA oligonucleotides to better visualize helicase activity

  • Strand annealing assay:

    • Use complementary oligonucleotides with one strand 5'-end labeled with [γ-³²P] ATP

    • Reaction buffer: 30 mM Tris-HCl pH 7.5, 50 mM KCl, 1 mM DTT, 5 mM MgCl₂, 100 μg/ml BSA

    • Incubate for 10 minutes at 37°C

    • Analyze by 10% native PAGE

    • RECQL4 exhibits strong strand annealing activity that can be enhanced by PARP1

  • Replication protein A (RPA) displacement assay:

    • Use single-stranded DNA coated with RPA

    • Add RECQL4 protein and assess displacement

    • This activity promotes microhomology annealing during alternative NHEJ repair

How do I reconcile conflicting reports about RECQL4 helicase activity?

The helicase activity of RECQL4 has been debated in the literature:

  • Historical contradiction:

    • Early reports claimed RECQL4 lacked helicase activity (Macris et al., 2006)

    • Later studies demonstrated that RECQL4 does possess weak helicase activity (Rossi et al., 2010)

  • Technical solutions:

    • The strong strand annealing activity of RECQL4 can mask its helicase activity

    • Add excess single-stranded DNA to helicase reactions to visualize activity

    • Alternatively, use short fork duplex DNA substrates for direct detection without excess ssDNA

    • Optimize reaction conditions: 30 mM Tris-HCl pH 7.4, 50 mM KCl, 5 mM MgCl₂

  • Experimental approach to resolve contradiction:

    • Compare RECQL4 helicase activity with other RecQ helicases (BLM, WRN) using identical substrates

    • Test influences of interacting partners (PARP1, PAR) on helicase activity

    • Use RECQL4 helicase-dead mutant (K508A) as a negative control

How can I address the dual role of RECQL4 in cancer (tumor suppressor vs. oncogene)?

RECQL4 exhibits context-dependent roles in cancer progression:

  • Contradictory observations:

    • Mutations in RECQL4 cause Rothmund-Thomson Syndrome with cancer predisposition (tumor suppressor role)

    • High expression of RECQL4 correlates with poor prognosis in several cancers (oncogenic role)

  • Experimental approaches to resolve this contradiction:

    • Compare RECQL4 expression levels across cancer types using tissue microarrays

    • Correlate expression with patient outcomes in specific cancer subtypes

    • In melanoma, high RECQL4 expression limits survival and serves as an independent prognostic factor

    • In TNBC, high RECQL4 expression correlates with better response to cisplatin therapy

  • Mechanistic studies:

    • Investigate RECQL4 overexpression effects on RAD51 foci formation

    • Measure DSB levels using neutral comet assay in cells with RECQL4 overexpression

    • Assess the relationship between RECQL4 levels and tumor mutation burden

    • Examine correlation between RECQL4 expression and immune cell infiltration in tumors

How do I investigate the relationship between RECQL4 and immune checkpoint inhibitor response?

Recent research has identified RECQL4 as a regulator of immune responses:

How can I investigate RECQL4's dual subcellular localization (nuclear vs. mitochondrial)?

RECQL4 is unique among RecQ helicases in its significant mitochondrial localization:

  • Visualization approaches:

    • Use immunofluorescence with multiple RECQL4 antibodies (Sigma, Santa Cruz) to confirm mitochondrial localization

    • Co-stain with MitoTracker Red to visualize mitochondria

    • Calculate coefficient of co-localization (reported values around 0.128)

  • Fractionation methods:

    • Isolate mitochondria using differential centrifugation

    • Generate mitoplasts by digitonin treatment to remove outer membrane

    • Use markers for different compartments: VDAC (outer mitochondrial membrane), Cox IV (inner membrane), tubulin (cytosolic contamination)

    • Analyze fractions by western blotting for RECQL4

  • Functional studies:

    • Measure mtDNA damage accumulation in RECQL4-deficient cells using Q-PCR

    • Perform microarray analysis to assess impact on mitochondrial bioenergetic pathways

    • Measure mitochondrial reserve capacity in RECQL4 knockdown cells

    • Investigate potential interaction between RECQL4 and mitochondrial DNA polymerase γ

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.